@hailbacon83
Aftereffect of a Multilayer, Extended-Release Methylphenidate Formula (PRC-063) about Slumber within Young people together with Attention-Deficit/Hyperactivity Condition: The Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Test As well as a new 6-Month Open-Label Follow-Up.